fashion -WSS

fashion

author：focus 2025-10-02 18:47:34 - browse：2728

A handout illustration representing Google’s DeepMind subsidiary and Isomorphic Labs developed an AI model that can accurately predict how a vast universe of biomolecules interact on an atomic level. — DeepMind

Google on Wednesday unveiled an artificial intelligence tool capable of predicting the structure and interaction of a vast universe of biomolecules, a fundamental advance that may help scientists unravel poorly understood aspects of biology and disease.

The new AI, dubbed AlphaFold 3, improves upon earlier versions of the model by predicting not just the structure of proteins, but all the molecules that interact with them in cells, including RNA, DNA, ions, and other small molecules.

Most new drugs consist of small molecules designed to bind to a protein involved in disease. AlphaFold 3 opens broader avenues of exploration, allowing scientists to rapidly examine complex interactions with other molecules that may highlight new disease targets — and different ways of attacking them.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Akero's treatment for NASH falls short in cirrhosis study

hotspot

WSS

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Novo Holdings to buy drug manufacturer Catalent in $16.5B deal

Bernie Sanders bashes nonprofit hospitals over their tax breaks

How doctors and nurses shape Google's AI

Akero's treatment for NASH falls short in cirrhosis study

A single Democrat is willing to weaken Medicare negotiation power

knowledge

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

In Memoriam: Notable people who died in 2023

Unique patient identifier: Experts argue the benefits, pitfalls

Bright Health sells Medicare Advantage business to Molina

Updated Covid vaccine has 54% effectiveness, new study suggests

Medicare details structure of new drug price negotiation program

Humana CEO Bruce Broussard to step down in 2024

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Medicare to cover more brain scans related to Alzheimer’s drugs

Alkermes shareholders re

Padmanee Sharma of MD Anderson at center of lawsuit over credit

focus

Gene therapy for Afghan refugees’ infant will be fully covered

European regulators recommend Amylyx's ALS drug be rejected

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Adopting new red light myopia treatments may be short

Gene therapy for Afghan refugees’ infant will be fully covered

Takeaways from AdvaMed, the largest medical devices conference

hotspot

explore

explore

leisure time